Fresenius Kabi Logo (Sti04 0001 01)
Stimufend Injection, Solution
Product Images NDC 65219-371
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Stimufend (NDC 65219-371). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure A (Sti04 0001 02)
An instructional diagram showing the components of a syringe assembly for STIMUFEND injection, solution 6 mg/0.6 mL. The labeled parts include the gray needle cap, medicine area on the syringe barrel, needle safety guard (unactivated), finger grips, and the plunger rod.*
Figure B (Sti04 0001 03)
An instructional diagram of a STIMUFEND 6 mg/.6 mL subcutaneous injection syringe, showing labeled parts including the clear needle guard, gray needle cap off, used plunger rod, needle, and needle safety guard. The image outlines the components involved in preparing the injection for administration.*
Figure C (Sti04 0001 04)
An illustration showing how to administer STIMUFEND (pegfilgrastim-fpgk) injection solution subcutaneously. The image depicts a hand holding the prefilled syringe and inserting the needle into the skin of the lower leg. The syringe is shown inside its protective packaging.*
Figure D (Sti04 0001 05)
An instructional illustration showing two syringes for administering STIMUFEND (pegfilgrastim-fpgk) 6 mg/0.6 mL injection solution. The left syringe, crossed out with a red 'X', shows an incorrect usage or configuration, while the right syringe, marked with a green checkmark, shows the correct method for subcutaneous injection.*
Figure E (Sti04 0001 06)
An instructional illustration showing a syringe with labeled parts including a gray needle cap, the medicine inside the syringe, and a label that contains the expiration date information. This image is used to demonstrate components of a prefilled syringe. No specific product branding or strength is visible.*
Figure F (Sti04 0001 07)
Illustration depicting components for subcutaneous injection administration. It includes a syringe prefilled with medication labeled STIMUFEND pegfilgrastim-fpgk, three small cotton balls, a folded gauze pad, a bandage strip, and a red sharps disposal container.*
Figures G And H (Sti04 0001 08)
Illustration showing recommended injection sites for subcutaneous administration. Labeled injection areas include the stomach area (abdomen), thigh, back area of upper arm, and upper outer area of the buttocks, depicted on a human figure from front and back views.*
Figure I (Sti04 0001 09)
An instructional illustration depicting a hand holding a syringe needle approaching a patch of skin, demonstrating a subcutaneous injection technique. The image likely supports guidance for the administration of the STIMUFEND injection solution.*
Figure J (Sti04 0001 10)
An instructional illustration showing a person removing a syringe from a vial labeled STIMUFEND (pegfilgrastim-fpgk) injection, solution 6 mg/0.6 mL. The image depicts a hand pulling the syringe upwards from the vial to withdraw the medication.*
Figure K (Sti04 0001 11)
An instructional illustration labeled 'Figure K' showing a hand pressing down on the white lid of a red biohazard sharps container, with a blue arrow indicating the downward pressing motion to close the container.*
Figure L (Sti04 0001 12)
An illustration showing the proper technique for subcutaneous injection on the upper arm. The figure includes arrows indicating the needle's angle and direction as it is inserted into the skin. Labeled as Figure L, it visually demonstrates injection administration for a medication such as STIMUFEND pegfilgrastim-fpgk injection.*
Figure M (Sti04 0001 13)
An instructional diagram illustrating the proper subcutaneous injection technique with a syringe held at a 45-degree angle to the skin. It shows a hand administering an injection into the forearm, demonstrating correct needle insertion angle for subcutaneous delivery.*
Figures N And O (Sti04 0001 14)
Illustration showing how to use the STIMUFEND injection pen. Figure N demonstrates pressing the pen against the skin for subcutaneous injection. Figure O provides a close-up of the user's thumb pressing the slider mechanism on the pen to administer the dose.*
Figure P (Sti04 0001 15)
An instructional illustration showing a hand holding a prefilled syringe with a blue plunger, positioned over a finger with an arrow indicating a downward motion, suggesting injection technique guidance for subcutaneous administration.*
Figure Q (Sti04 0001 16)
An instructional illustration showing a hand holding a syringe with a blue cap removed, positioned above a red sharps disposal container. The image likely depicts proper disposal or handling of the injection device for STIMUFEND pegfilgrastim-fpgk subcutaneous injection solution.*
Figure R (Sti04 0001 17)
Illustration showing a hand pressing a cotton ball or similar absorbent pad onto a surface, likely demonstrating a post-injection care step such as applying pressure to the injection site.*
Fresenius Kabi Logo (Sti04 0001 18)
Package Label – Principal Display – Stimufend –one 0.6 mL Single-dose Prefilled Syringe Carton Panel (Sti04 0001 19)
Packaging label for STIMUFEND pegfilgrastim-fpgk injection, 6 mg/0.6 mL strength, in a single-dose pre-filled syringe for subcutaneous use. The label includes the Fresenius Kabi USA, LLC logo and states the product contains dry natural rubber sterile solution with no preservative. The label also details storage instructions and cautions about the product's seal integrity.*
Package Label – Principal Display – Stimufend – 0.6 mL Single-dose Prefilled Syringe Blister Pack Label (Sti04 0001 20)
STIMUFEND injection label for 6 mg / 0.6 mL solution in a single-dose pre-filled syringe. The label shows pegfilgrastim-fpgk as the active ingredient, indicates subcutaneous use, and provides storage instructions. Manufactured by Fresenius Kabi USA, LLC in Italy, the label includes the product NDC 65219-371-10 and notes no U.S. standard of potency.*
Package Label – Principal Display – Stimufend – 0.6 mL Single-dose Prefilled Syringe Label (Sti04 0001 21)
Label for StimuFend (pegfilgrastim-fpgk) Injection showing a dosage strength of 6 mg per 0.6 mL. The label is pink with the brand name in blue and includes a barcode, U.S. License No. 2146, and the labeler name Fresenius Kabi USA LLC.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
